Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

410972 IDH1 Inhibitor, R132 Somatic Mutant-Specific, AGI-5198 - CAS 1355326-35-0 - Calbiochem

IDH1 Inhibitor, R132 Somatic Mutant-Specific, AGI-5198 - CAS 1355326-35-0 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: N-Cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide, HCl, AGI-5198, AGI-5198, Isocitrate Dehydrogenase 1 R132 Somatic Mutant Inhibitor, AGI-5198

410972
  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Overview

This product has been discontinued.



A cell-permeable phenyl-glycine analog that acts as an IDH1 (Isocitrate Dehydrogenase 1) R132 somatic mutant-specific inhibitor (IC50 = 0.07, 0.16, and >100 µM, respectively, against R132H, R132C, and wt IDH1), potently inhibiting oncometabolite 2-HG (D-2-hydroxyglutarate) production, but not cancer viability, in R132H-harboring U87-MG glioblastoma and R132C-harboring HT1080 chondrosarcoma cultures in vitro (IC50 = 70 and 480 nM, respectively; 48 h) and in R132H U87-MG tumor-bearing mice in vivo (150 mg/kg/12 h i.p.). Oncometabolite 2-HG acts as an α-KG-competitive inhibitor against multiple α-KG-dependent enzymes that are important in maintaining normal cellular functions, including epigenetic regulations.
Catalogue Number410972
Brand Family Calbiochem®
SynonymsN-Cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide, HCl, AGI-5198, AGI-5198, Isocitrate Dehydrogenase 1 R132 Somatic Mutant Inhibitor, AGI-5198
References
ReferencesRohle, D., et al. 2013. Science 340, 626.
Popovici-Muller, J., et al. 2012. ACS Med. Chem. Lett. 3, 850.
Product Information
CAS number1355326-35-0
FormOff-white powder
Hill FormulaC₂₇H₃₁FN₄O₂ • HCl
Chemical formulaC₂₇H₃₁FN₄O₂ • HCl
Hygroscopic Hygroscopic
ReversibleY
Structure formula ImageStructure formula Image
Applications
Biological Information
Primary Targetactive site IDH1 mutant homodimer
Primary Target IC<sub>50</sub>0.07, 0.16, and >
Purity≥98% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
410972 0

Documentation

IDH1 Inhibitor, R132 Somatic Mutant-Specific, AGI-5198 - CAS 1355326-35-0 - Calbiochem Certificates of Analysis

TitleLot Number
410972

References

Reference overview
Rohle, D., et al. 2013. Science 340, 626.
Popovici-Muller, J., et al. 2012. ACS Med. Chem. Lett. 3, 850.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision06-September-2013 JSW
SynonymsN-Cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide, HCl, AGI-5198, AGI-5198, Isocitrate Dehydrogenase 1 R132 Somatic Mutant Inhibitor, AGI-5198
DescriptionA cell-permeable phenyl-glycine analog that acts as an IDH1 (Isocitrate Dehydrogenase 1) R132 somatic mutant-specific inhibitor (IC50 = 0.07, 0.16, and >100 µM, respectively, against R132H, R132C, and wt IDH1) and potently inhibits R132 somatic mutant-catalyzed α-KG (α-ketoglutarate) to 2-HG (D-2-hydroxyglutarate) conversion in R132H-harboring U87-MG glioblastoma and R132C-harboring HT1080 chondrosarcoma cultures (IC50 = 70 and 480 nM, respectively; 48 h), without interfering with cell growth (GI50 > 20 µM; 72 h in R132 mutant-harboring HT1080 and U87-MG cutlures) or wild-type enzyme-catalyzed α-KG production. Shown to suppresses R132H U87-MG tumor 2-HG production in mice in vivo albeit that a frequent and heavy i.p. dosing regiment (max inhibtion = 89% at 4 h after three 150 mg/kg/12 h i.p. dosings) is needed to maintain effective free inhibitor concentration in plasma. Oncometabolite 2-HG acts as an α-KG-competitive inhibitor against multiple α-KG-dependent enzymes that are important in maintaining normal cellular functions, including epigenetic regulations.
FormOff-white powder
Intert gas (Yes/No) Packaged under inert gas
CAS number1355326-35-0
Chemical formulaC₂₇H₃₁FN₄O₂ • HCl
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityDMSO (100 mg/ml) or H₂O (2.5 mg/mL)
Storage Protect from light
+2°C to +8°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesRohle, D., et al. 2013. Science 340, 626.
Popovici-Muller, J., et al. 2012. ACS Med. Chem. Lett. 3, 850.